{
    "4 24 2025": {
        "importantArticles": [
            {
                "headline": "Edwards Lifesciences (NYSE:EW) recently announced its updated guidance, projecting second-quarter 2025 sales between $1.45 billion and $1.53 billion, alongside first-quarter results showing a rise in sales and net income compared to the previous year. This aligns with a broader market trend where the S&P 500 and Nasdaq Composite surged, driven by positive earnings reports and easing concerns over tariffs. The company's 2.2% price move over the last quarter reflects the general optimism but...",
                "publication_date": "2025-04-24T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.8442",
                "source": "Simply Wall St.",
                "ticker": "EW",
                "title": "Edwards Lifesciences (NYSE:EW) Projects 2025 Sales Over US$5.7 Billion With Strong Earnings",
                "url": "https://finance.yahoo.com/news/edwards-lifesciences-nyse-ew-projects-182517631.html"
            },
            {
                "headline": "Edwards Lifesciences' first-quarter 2025 performance benefits from its differentiated portfolio of therapies to treat patients with structural heart disease.",
                "publication_date": "2025-04-24T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.6486",
                "source": "Zacks",
                "ticker": "EW",
                "title": "EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View Raised",
                "url": "https://finance.yahoo.com/news/ew-q1-earnings-revenues-beat-104300387.html"
            },
            {
                "headline": "Edwards Lifesciences Corp (EW) reports an 8% increase in total sales, raises full-year guidance, and achieves significant product approvals in Q1 2025.",
                "publication_date": "2025-04-24T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.4767",
                "source": "GuruFocus.com",
                "ticker": "EW",
                "title": "Edwards Lifesciences Corp (EW) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...",
                "url": "https://finance.yahoo.com/news/edwards-lifesciences-corp-ew-q1-070815654.html"
            },
            {
                "headline": "The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity constraints that have dogged its core business.",
                "publication_date": "2025-04-24T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "MedTech Dive",
                "ticker": "EW",
                "title": "Edwards shrugs off tariffs, backs 2025 profit forecast",
                "url": "https://finance.yahoo.com/news/edwards-shrugs-off-tariffs-backs-110405685.html"
            },
            {
                "headline": "Q1 2025 Edwards Lifesciences Corp Earnings Call",
                "publication_date": "2025-04-24T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Thomson Reuters StreetEvents",
                "ticker": "EW",
                "title": "Q1 2025 Edwards Lifesciences Corp Earnings Call",
                "url": "https://finance.yahoo.com/news/q1-2025-edwards-lifesciences-corp-125057955.html"
            },
            {
                "headline": "Texas Instruments, Mondelez downgraded: Wall Street's top analyst calls",
                "publication_date": "2025-04-24T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.2023",
                "source": "The Fly",
                "ticker": "EW",
                "title": "Texas Instruments, Mondelez downgraded: Wall Street's top analyst calls",
                "url": "https://finance.yahoo.com/news/texas-instruments-mondelez-downgraded-wall-133458255.html"
            }
        ],
        "avgScore": 0.3783571428571429,
        "pctChange": 0.012533697350749192
    },
    "4 23 2025": {
        "importantArticles": [
            {
                "headline": "IRVINE, Calif., April 23, 2025--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Mar. 31, 2025.",
                "publication_date": "2025-04-23T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Business Wire",
                "ticker": "EW",
                "title": "Edwards Lifesciences Reports First Quarter Results",
                "url": "https://finance.yahoo.com/news/edwards-lifesciences-reports-first-quarter-201500800.html"
            },
            {
                "headline": "IRVINE, Calif., April 23, 2025--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Mar. 31, 2025.",
                "publication_date": "2025-04-23T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Business Wire",
                "ticker": "EW",
                "title": "Edwards Lifesciences Reports First Quarter Results",
                "url": "https://finance.yahoo.com/news/edwards-lifesciences-reports-first-quarter-201500800.html"
            }
        ],
        "avgScore": 0.0,
        "pctChange": 0.06627871458452013
    },
    "4 21 2025": {
        "importantArticles": [
            {
                "headline": "Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and competitive dynamics in key markets.",
                "publication_date": "2025-04-21T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.5719",
                "source": "MedTech Dive",
                "ticker": "EW",
                "title": "Intuitive, Boston Scientific and Edwards next up in medtech earnings",
                "url": "https://finance.yahoo.com/news/intuitive-boston-scientific-edwards-next-100000135.html"
            },
            {
                "headline": "Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and competitive dynamics in key markets.",
                "publication_date": "2025-04-21T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.5719",
                "source": "MedTech Dive",
                "ticker": "EW",
                "title": "Intuitive, Boston Scientific and Edwards next up in medtech earnings",
                "url": "https://finance.yahoo.com/news/intuitive-boston-scientific-edwards-next-100000135.html"
            }
        ],
        "avgScore": 0.5719,
        "pctChange": 0.02023123681531418
    },
    "4 17 2025": {
        "importantArticles": [
            {
                "headline": "EW's first-quarter 2025 performance is likely to have gained from growth drivers across its businesses amid macroeconomic headwinds.",
                "publication_date": "2025-04-17T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.6369",
                "source": "Zacks",
                "ticker": "EW",
                "title": "Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings",
                "url": "https://finance.yahoo.com/news/solid-tmtt-growth-drive-edwards-123100665.html"
            },
            {
                "headline": "EW's first-quarter 2025 performance is likely to have gained from growth drivers across its businesses amid macroeconomic headwinds.",
                "publication_date": "2025-04-17T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.6369",
                "source": "Zacks",
                "ticker": "EW",
                "title": "Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings",
                "url": "https://finance.yahoo.com/news/solid-tmtt-growth-drive-edwards-123100665.html"
            }
        ],
        "avgScore": 0.6369,
        "pctChange": -0.03257377143600716
    },
    "4 16 2025": {
        "importantArticles": [
            {
                "headline": "IRVINE, Calif., April 16, 2025--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2025 after the market closes on Wednesday April 23, 2025, and will host a conference call at 5:00 p.m. ET that day to discuss those results.",
                "publication_date": "2025-04-16T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Business Wire",
                "ticker": "EW",
                "title": "Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025",
                "url": "https://finance.yahoo.com/news/edwards-lifesciences-host-earnings-conference-110500034.html"
            },
            {
                "headline": "IRVINE, Calif., April 16, 2025--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2025 after the market closes on Wednesday April 23, 2025, and will host a conference call at 5:00 p.m. ET that day to discuss those results.",
                "publication_date": "2025-04-16T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Business Wire",
                "ticker": "EW",
                "title": "Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025",
                "url": "https://finance.yahoo.com/news/edwards-lifesciences-host-earnings-conference-110500034.html"
            }
        ],
        "avgScore": 0.0,
        "pctChange": 0.004634857376392552
    },
    "4 15 2025": {
        "importantArticles": [
            {
                "headline": "The replacement system is launching into markets already served by repair devices, namely Edwards\u2019 Pascal and Abbott\u2019s Mitraclip.",
                "publication_date": "2025-04-15T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "MedTech Dive",
                "ticker": "EW",
                "title": "Edwards receives CE mark for Sapien M3 mitral valve replacement device",
                "url": "https://finance.yahoo.com/news/edwards-receives-ce-mark-sapien-033327697.html"
            },
            {
                "headline": "The replacement system is launching into markets already served by repair devices, namely Edwards\u2019 Pascal and Abbott\u2019s Mitraclip.",
                "publication_date": "2025-04-15T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "MedTech Dive",
                "ticker": "EW",
                "title": "Edwards receives CE mark for Sapien M3 mitral valve replacement device",
                "url": "https://finance.yahoo.com/news/edwards-receives-ce-mark-sapien-033327697.html"
            }
        ],
        "avgScore": 0.0,
        "pctChange": 0.0062181288684053475
    },
    "4 14 2025": {
        "importantArticles": [
            {
                "headline": "Edwards\u2019 mitral valve implant approval in Europe mounts a challenge to long-time market dominator Abbott.",
                "publication_date": "2025-04-14T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.5267",
                "source": "Medical Device Network",
                "ticker": "EW",
                "title": "Edwards secures CE mark for transfemoral mitral valve implant",
                "url": "https://finance.yahoo.com/news/edwards-secures-ce-mark-transfemoral-160758015.html"
            },
            {
                "headline": "IRVINE, Calif., April 14, 2025--Edwards Lifesciences Corporation (NYSE: EW) today announced the company\u2019s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter edge-to-edge (TEER) therapy. Leveraging the company\u2019s SAPIEN technology, the SAPIEN M3 system is the world's first approved transcatheter valve replacement therap",
                "publication_date": "2025-04-14T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.4215",
                "source": "Business Wire",
                "ticker": "EW",
                "title": "Edwards SAPIEN M3 Receives CE Mark, Becoming World\u2019s First Transfemoral Transcatheter Mitral Valve Replacement System",
                "url": "https://finance.yahoo.com/news/edwards-sapien-m3-receives-ce-120000668.html"
            },
            {
                "headline": "IRVINE, Calif., April 14, 2025--Edwards Lifesciences Corporation (NYSE: EW) today announced the company\u2019s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter edge-to-edge (TEER) therapy. Leveraging the company\u2019s SAPIEN technology, the SAPIEN M3 system is the world's first approved transcatheter valve replacement therap",
                "publication_date": "2025-04-14T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.4215",
                "source": "Business Wire",
                "ticker": "EW",
                "title": "Edwards SAPIEN M3 Receives CE Mark, Becoming World\u2019s First Transfemoral Transcatheter Mitral Valve Replacement System",
                "url": "https://finance.yahoo.com/news/edwards-sapien-m3-receives-ce-120000668.html"
            },
            {
                "headline": "Edwards\u2019 mitral valve implant approval in Europe mounts a challenge to long-time market dominator Abbott.",
                "publication_date": "2025-04-14T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.5267",
                "source": "Medical Device Network",
                "ticker": "EW",
                "title": "Edwards secures CE mark for transfemoral mitral valve implant",
                "url": "https://finance.yahoo.com/news/edwards-secures-ce-mark-transfemoral-160758015.html"
            }
        ],
        "avgScore": 0.47409999999999997,
        "pctChange": 0.012737932655827401
    },
    "4 8 2025": {
        "importantArticles": [
            {
                "headline": "Edwards stock shot higher Thursday after the medtech player said tariffs are likely to have little impact in 2025.",
                "publication_date": "2025-04-08T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Investor's Business Daily",
                "ticker": "EW",
                "title": "Edwards Shoots Higher As It Shrugs Off Tariffs Worries \u2014 Until 2026",
                "url": "https://finance.yahoo.com/m/ea63a7d1-a8f2-39ec-902e-013664ff0d3b/edwards-shoots-higher-as-it.html"
            },
            {
                "headline": "Edwards stock shot higher Thursday after the medtech player said tariffs are likely to have little impact in 2025.",
                "publication_date": "2025-04-08T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Investor's Business Daily",
                "ticker": "EW",
                "title": "Edwards Shoots Higher As It Shrugs Off Tariffs Worries \u2014 Until 2026",
                "url": "https://finance.yahoo.com/m/ea63a7d1-a8f2-39ec-902e-013664ff0d3b/edwards-shoots-higher-as-it.html"
            }
        ],
        "avgScore": 0.0,
        "pctChange": 0.04219474942495159
    },
    "4 1 2025": {
        "importantArticles": [
            {
                "headline": "Sands Capital, an investment management company, released its \u201cSands Capital Select Growth Fund\u201d Q4 2024 investor letter. A copy of the same can be downloaded here. Select Growth primarily targets U.S. companies that are leading the way in crucial areas of positive structural transformation within the economy. The fund returned 8.8% (net) in the fourth [\u2026]",
                "publication_date": "2025-04-01T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.8316",
                "source": "Insider Monkey",
                "ticker": "EW",
                "title": "Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities",
                "url": "https://finance.yahoo.com/news/sands-capital-select-growth-fund-131821494.html"
            },
            {
                "headline": "Edwards Lifesciences (NYSE:EW) recently announced significant findings at the ACC Annual Scientific Session, showcasing crucial research in the treatment of structural heart disease. This development, alongside data indicating the increased effectiveness of electronic notifications in treating severe aortic stenosis, comes amid broader market volatility. The past week saw a 1.58% rise in Edwards Lifesciences' stock, contrasting with a 3.4% drop in the overall market as concerns about tariffs...",
                "publication_date": "2025-04-01T00:00:00.000Z",
                "sentiment": "Negative",
                "sentimentScore": "-0.2023",
                "source": "Simply Wall St.",
                "ticker": "EW",
                "title": "Edwards Lifesciences (NYSE:EW) Presents Promising AS Treatment Data At ACC Session",
                "url": "https://finance.yahoo.com/news/edwards-lifesciences-nyse-ew-presents-174948594.html"
            },
            {
                "headline": "Edwards Lifesciences (NYSE:EW) recently announced significant findings at the ACC Annual Scientific Session, showcasing crucial research in the treatment of structural heart disease. This development, alongside data indicating the increased effectiveness of electronic notifications in treating severe aortic stenosis, comes amid broader market volatility. The past week saw a 1.58% rise in Edwards Lifesciences' stock, contrasting with a 3.4% drop in the overall market as concerns about tariffs...",
                "publication_date": "2025-04-01T00:00:00.000Z",
                "sentiment": "Negative",
                "sentimentScore": "-0.2023",
                "source": "Simply Wall St.",
                "ticker": "EW",
                "title": "Edwards Lifesciences (NYSE:EW) Presents Promising AS Treatment Data At ACC Session",
                "url": "https://finance.yahoo.com/news/edwards-lifesciences-nyse-ew-presents-174948594.html"
            },
            {
                "headline": "Sands Capital, an investment management company, released its \u201cSands Capital Select Growth Fund\u201d Q4 2024 investor letter. A copy of the same can be downloaded here. Select Growth primarily targets U.S. companies that are leading the way in crucial areas of positive structural transformation within the economy. The fund returned 8.8% (net) in the fourth [\u2026]",
                "publication_date": "2025-04-01T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.8316",
                "source": "Insider Monkey",
                "ticker": "EW",
                "title": "Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities",
                "url": "https://finance.yahoo.com/news/sands-capital-select-growth-fund-131821494.html"
            }
        ],
        "avgScore": 0.31465,
        "pctChange": 0.0025045262042144786
    },
    "3 31 2025": {
        "importantArticles": [
            {
                "headline": "We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. In this article, we are going to take a look at where Edwards Lifesciences (NYSE:EW) stands against other stocks that Jim Cramer put under a microscope. On Thursday, Jim Cramer, the host of Mad Money, shared his thoughts on the [\u2026]",
                "publication_date": "2025-03-31T00:00:00.000Z",
                "sentiment": "Negative",
                "sentimentScore": "-0.2023",
                "source": "Insider Monkey",
                "ticker": "EW",
                "title": "Jim Cramer Calls Edwards Lifesciences (EW) a Hold \u2013 Prefers Boston Scientific Right Now!",
                "url": "https://finance.yahoo.com/news/jim-cramer-calls-edwards-lifesciences-134333052.html"
            },
            {
                "headline": "CHICAGO, March 31, 2025--Edwards Lifesciences (NYSE: EW) today announced new scientific evidence presented and published during the American College of Cardiology\u2019s (ACC) Annual Scientific Session & Expo, addressing the critical needs of patients with structural heart disease.",
                "publication_date": "2025-03-31T00:00:00.000Z",
                "sentiment": "Negative",
                "sentimentScore": "-0.3182",
                "source": "Business Wire",
                "ticker": "EW",
                "title": "New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients",
                "url": "https://finance.yahoo.com/news/data-confirm-rapid-unpredictable-progression-180000685.html"
            },
            {
                "headline": "CHICAGO, March 31, 2025--Edwards Lifesciences (NYSE: EW) today announced new scientific evidence presented and published during the American College of Cardiology\u2019s (ACC) Annual Scientific Session & Expo, addressing the critical needs of patients with structural heart disease.",
                "publication_date": "2025-03-31T00:00:00.000Z",
                "sentiment": "Negative",
                "sentimentScore": "-0.3182",
                "source": "Business Wire",
                "ticker": "EW",
                "title": "New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients",
                "url": "https://finance.yahoo.com/news/data-confirm-rapid-unpredictable-progression-180000685.html"
            },
            {
                "headline": "We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. In this article, we are going to take a look at where Edwards Lifesciences (NYSE:EW) stands against other stocks that Jim Cramer put under a microscope. On Thursday, Jim Cramer, the host of Mad Money, shared his thoughts on the [\u2026]",
                "publication_date": "2025-03-31T00:00:00.000Z",
                "sentiment": "Negative",
                "sentimentScore": "-0.2023",
                "source": "Insider Monkey",
                "ticker": "EW",
                "title": "Jim Cramer Calls Edwards Lifesciences (EW) a Hold \u2013 Prefers Boston Scientific Right Now!",
                "url": "https://finance.yahoo.com/news/jim-cramer-calls-edwards-lifesciences-134333052.html"
            }
        ],
        "avgScore": -0.26025,
        "pctChange": -0.008416122821456913
    },
    "coef": -0.05627748595326502,
    "avgCoef": -0.016285525800837426,
    "similar": {
        "TAL": 0.3126526997403612,
        "TEM": 0.2876404837611323,
        "LUV": 0.27513437577151784,
        "PFE": 0.25637521378709616
    }
}